<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="3-part\PMC7045083\results\search\disease\results.xml">
  <result pre="Science pmcid: 7045083S0264-410X(20)30112-2 doi: 10.1016/j.vaccine.2020.01.070 : Article Symptoms associated with" exact="influenza" post="vaccination and experimental human pneumococcal colonisation of the nasopharynx"/>
  <result pre="CC BY license (http://creativecommons.org/licenses/by/4.0/). Highlights •The timing and route of" exact="influenza" post="vaccines effect symptom reporting in healthy adults. •Symptoms experienced"/>
  <result pre="pneumococcal infections. Influenza co-infection leads to increased susceptibility to secondary" exact="pneumonia" post="and mortality during influenza epidemics. Increased bacterial load and"/>
  <result pre="leads to increased susceptibility to secondary pneumonia and mortality during" exact="influenza" post="epidemics. Increased bacterial load and impaired immune responses to"/>
  <result pre="bacterial load and impaired immune responses to pneumococcus caused by" exact="influenza" post="play a role in this increased susceptibility. Using an"/>
  <result pre="this increased susceptibility. Using an Experimental Human Challenge Model and" exact="influenza" post="vaccines, we examined symptoms experienced by healthy adults during"/>
  <result pre="adults during nasal co-infection with S. pneumoniae and live attenuated" exact="influenza" post="virus. Methods Randomised, blinded administration of Live Attenuated Influenza"/>
  <result pre="days post second intervention. Results The timing and type of" exact="influenza" post="vaccination and presence of S. pneumoniae in the nasopharynx"/>
  <result pre="the nasopharynx significantly affected symptom reporting. In the study where" exact="influenza" post="vaccination preceded bacterial inoculation: nasal symptoms were less common"/>
  <result pre="13/38 [34.21%], respectively; p &amp;lt; 0.05). In the study where" exact="influenza" post="vaccination followed bacterial inoculation: no difference was seen in"/>
  <result pre="human infection challenge model Influenza vaccination Pneumococcal inoculation Live attenuated" exact="influenza" post="vaccine Pneumococcus colonisation Streptococcus pneumoniae Symptoms 1 Introduction Nasopharyngeal"/>
  <result pre="colonisation by S. pneumoniae is a prerequisite for pneumonia, meningitis," exact="sinusitis" post="and otitis media [1], [2]. Reports suggest that point"/>
  <result pre="S. pneumoniae is a prerequisite for pneumonia, meningitis, sinusitis and" exact="otitis media" post="[1], [2]. Reports suggest that point prevalence of colonisation"/>
  <result pre="can lead to secondary pneumonia, which frequently drives mortality during" exact="influenza" post="epidemics [12], [13], [14]. LAIV is safe and effective"/>
  <result pre="the symptoms experienced by healthy adults during nasal co-infection with" exact="influenza" post="and S. pneumoniae, and examine the importance of order"/>
  <result pre="involved two sequentially recruited cohorts. The ‘antecedent’ cohort (2015/16) received" exact="influenza" post="vaccine 3 days prior to nasal inoculation with Streptococcus"/>
  <result pre="reversed this order (pneumococcal inoculation was performed 3 days before" exact="influenza" post="vaccine administration). Full cohort details have been previously described"/>
  <result pre="healthy, non-smoking adults, aged 18–50 years old. Exclusion criteria were:" exact="influenza" post="or pneumococcal vaccination; clinically confirmed pneumococcal disease in the"/>
  <result pre="are observed after challenge with S. pneumoniae We investigated whether" exact="influenza" post="vaccination led to symptoms in healthy adults. Apart from"/>
  <result pre="Participants were first inoculated with S. pneumoniae and then received" exact="influenza" post="vaccines 3 days later. 163 participants completed the primary"/>
  <result pre="to symptoms in healthy adults in the absence of any" exact="influenza" post="vaccine in the three days prior to the administration"/>
  <result pre="pneumoniae and subsequently in the 3 days after receiving an" exact="influenza" post="vaccination. Colonisation status of the participant did not affect"/>
  <result pre="the first study to evaluate symptoms associated with live attentuated" exact="influenza" post="vaccine and controlled pneumococcal colonisation. The timing and route"/>
  <result pre="vaccine and controlled pneumococcal colonisation. The timing and route of" exact="influenza" post="vaccination, and the presence of S. pneumoniae in the"/>
  <result pre="increase in bacterial densities at Day 28, with symptoms of" exact="rhinitis" post="positively associated with pneumococcal density [17]. We used an"/>
  <result pre="the exact day of pneumococcal exposure in relation to the" exact="influenza" post="vaccination and the timing and duration of pneumococcal colonisation."/>
  <result pre="in adults: a longitudinal household studyJ Infect Dis1923200538739315995951 4RodriguesF.FosterD.NicoliE.TrotterC.VipondB.MuirP.Relationships between" exact="rhinitis" post="symptoms, respiratory viral infections and nasopharyngeal colonization with streptococcus"/>
  <result pre="Am667201810451053 7BlockS.L.YiT.SheldonE.DubovskyF.FalloonJ.A randomized, double-blind noninferiority study of quadrivalent live attenuated" exact="influenza" post="vaccine in adultsVaccine295020119391939721983154 8AdetifaI.M.O.AntonioM.OkoromahC.A.N.EbrukeC.InemV.NsekpongD.Pre-vaccination nasopharyngeal pneumococcal carriage in a"/>
  <result pre="adults using an experimental human colonisation modelbioRxiv2019 12MorensD.M.TaubenbergerJ.K.FauciA.S.Predominant role of" exact="bacterial pneumonia" post="as a cause of death in pandemic influenza: implications"/>
  <result pre="using an experimental human colonisation modelbioRxiv2019 12MorensD.M.TaubenbergerJ.K.FauciA.S.Predominant role of bacterial" exact="pneumonia" post="as a cause of death in pandemic influenza: implications"/>
  <result pre="a cause of death in pandemic influenza: implications for pandemic" exact="influenza" post="preparednessJ Infect Dis1987200896297018710327 13SiegelS.J.RocheA.M.WeiserJ.N.Influenza promotes pneumococcal growth during co-infection"/>
  <result pre="substrates as a nutrient sourceCell Host Microbe1612014556725011108 14WadowskyR.MietznerS.SkonerD.DoyleW.FiremanP.Effect of experimental" exact="influenza" post="A virus infection on isolation of Streptococcus pneumoniae and"/>
  <result pre="vaccine in childrenN Engl J Med338201998140514129580647 16RhorerJ.AmbroseC.S.DickinsonS.HamiltonH.OlekaN.A.MalinoskiF.J.Efficacy of live attenuated" exact="influenza" post="vaccine in children: A meta-analysis of nine randomized clinical"/>
  <result pre="randomized clinical trialsVaccine2772009 Feb 111101111019095024 17ThorsV.ChristensenH.Morales-AzaB.VipondI.MuirP.FinnA.The effects of live attenuated" exact="influenza" post="vaccine on nasopharyngeal bacteria in healthy 2 to 4"/>
  <result pre="study group. Two randomized trials of effect of live attenuated" exact="influenza" post="vaccine on pneumococcal colonizationAm J Respir Crit Care Med199920191160116330758980"/>
  <result pre="local inflammation facilitate transmission of Streptococcus pneumoniaemBio352012 20JochemsS.P.MarconF.CarnielB.F.HollowayM.MitsiE.SmithE.Inflammation induced by" exact="influenza" post="virus impairs human innate immune control of pneumococcusNat Immunol2919201812991308"/>
 </snippets>
</snippetsTree>
